PRIMECAP MANAGEMENT CO/CA/
Institutional investor · Portfolio as of Q2 2020
Top Holdings306 positions
Eli Lilly & Co. | 39.6M | $6.5B | 5.6% | $104.89 | +46.36% | 7 qtrssince 2018-Q4 | Decreased 0 |
Microsoft Corp. | 23.9M | $4.9B | 4.2% | $94.43 | +104.45% | 7 qtrssince 2018-Q4 | Decreased 0 |
Adobe Inc | 11M | $4.8B | 4.1% | $226.24 | +92.41% | 7 qtrssince 2018-Q4 | Decreased 0 |
Amgen Inc. | 18M | $4.2B | 3.6% | $154.26 | +26.30% | 7 qtrssince 2018-Q4 | Decreased 0 |
BIOGEN INC | 15.6M | $4.2B | 3.6% | $301.43 | -11.24% | 7 qtrssince 2018-Q4 | Decreased 0 |
Texas Instruments Inc. | 26.4M | $3.3B | 2.9% | $76.19 | +40.21% | 7 qtrssince 2018-Q4 | Decreased 0 |
ALIBABA GROUP HLDG LTD | 13.2M | $2.8B | 2.4% | $128.99 | +57.36% | 7 qtrssince 2018-Q4 | Decreased 0 |
ASTRAZENECA PLC | 53.7M | $2.8B | 2.4% | $62.04 | +52.44% | 7 qtrssince 2018-Q4 | Decreased 0 |
Micron Technology Inc. | 51.5M | $2.7B | 2.3% | $30.94 | +62.37% | 7 qtrssince 2018-Q4 | Decreased 0 |
SOUTHWEST AIRLS CO | 69.2M | $2.4B | 2.0% | $41.74 | -24.82% | 7 qtrssince 2018-Q4 | Increased 56 |
Alphabet Inc. | 1.6M | $2.3B | 2.0% | $51.76 | +35.69% | 7 qtrssince 2018-Q4 | Decreased 0 |
SONY CORP | 33M | $2.3B | 2.0% | $9.26 | +44.79% | 7 qtrssince 2018-Q4 | Decreased 0 |
BIOMARIN PHARMACEUTICAL INC | 17.9M | $2.2B | 1.9% | $84.35 | +46.23% | 7 qtrssince 2018-Q4 | Increased 50 |
NOVARTIS AG | 23.3M | $2B | 1.7% | $58.53 | +18.97% | 7 qtrssince 2018-Q4 | Decreased 0 |
Alphabet Inc. | 1.4M | $2B | 1.7% | $51.29 | +36.50% | 7 qtrssince 2018-Q4 | Decreased 0 |
KLA Corp. | 10M | $1.9B | 1.7% | $8.13 | +124.10% | 7 qtrssince 2018-Q4 | Decreased 0 |
QUALCOMM INC | 21.2M | $1.9B | 1.7% | $47.38 | +68.55% | 7 qtrssince 2018-Q4 | Decreased 0 |
FEDEX CORP | 13.6M | $1.9B | 1.6% | $113.18 | -10.83% | 7 qtrssince 2018-Q4 | Decreased 0 |
Thermo Fisher Scientific Inc | 4.7M | $1.7B | 1.5% | $220.30 | +61.73% | 7 qtrssince 2018-Q4 | Decreased 0 |
JPMorgan Chase & Co. | 17.3M | $1.6B | 1.4% | $79.11 | +1.04% | 7 qtrssince 2018-Q4 | Decreased 0 |
PRIMECAP MANAGEMENT CO/CA/ manages $116.5B across 306 positions as of Q2 2020. Top holdings: LLY (5.6%), MSFT (4.2%), ADBE (4.1%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.
Active quarter - 20 new positions, 10 exits, 58 increased. Top move: LUV (INCREASED, conviction 56). Portfolio: $116.5B across 306 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR